Professor Cohen serves as Director of Myeloma Immunotherapy, is a member of the Clinical Trial Scientific Review and Monitoring Committee and co-director of the Amyloidosis Program. Professor Cohen’s research expertise includes cancer immunotherapy, vaccines, cellular therapy, Phase I trials and CAR T cells. He has written dozens of original articles, book chapters, and reviews on DNA vaccines, tumor immunity, multiple myeloma, amyloidosis, and stem cell transplantation.